Revelation Biosciences Inc expected to post a loss of $2.29 a share - Earnings Preview

Revelation Biosciences

08/11/2024 23:15

* Revelation Biosciences Inc  REVB.OQ   REVB.O  is expected
to show no change in quarterly revenue when it reports 
results on November 8 for the period ending December 31 2024
    * 
    * ​LSEG's mean analyst estimate for Revelation Biosciences
Inc is
for a loss of $2.29 per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts had fallen by
about 36.2%
in the last three months. ​
    * Wall Street's median 12-month price target for Revelation
Biosciences Inc is 14.45​, above​ its last closing price
of $0.85. ​​​

This summary was machine generated November 8 at 23:15 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)